Integration of Modbus and AI in Medical Device Communications: Current Advancements (As of May 2025) I. Protocol Conversion and Multimodal Data Integration Cross-Protocol Intelligent Gateways Advanced gateways like the JH-ECT002 enable bidirectional communication between high-precision imaging devic … Integration of Modbus and AI in Medical Device Communications: Current AdvancementsRead more
AI
AI（Artificial Intelligence，人工智能）
AI-Driven Technologies in NCL Research: Revolutionizing Drug Development for Neuronal Ceroid Lipofuscinosis
AI-Driven Technologies in NCL Research: Revolutionizing Drug Development for Neuronal Ceroid Lipofuscinosis (As of May 2025) I. Target Discovery and Mechanistic Insights Multimodal Biomedical Knowledge Graphs AI integrates global scientific literature, genomic databases, and clinical case reports us … AI-Driven Technologies in NCL Research: Revolutionizing Drug Development for Neuronal Ceroid LipofuscinosisRead more
FPGAnext and AI-Assisted Diagnostics: Redefining Precision Medicine through Advanced Programmable Logic
FPGAnext and AI-Assisted Diagnostics: Redefining Precision Medicine through Advanced Programmable Logic FPGAnext, a next-generation field-programmable gate array (FPGA) technology, is revolutionizing AI-assisted diagnostics with its dynamic hardware reconfiguration and heterogeneous computing archit … FPGAnext and AI-Assisted Diagnostics: Redefining Precision Medicine through Advanced Programmable LogicRead more
AI-Driven Drug Discovery (BioAI Pharma) and Its Impact on Healthcare Equity (2025 Assessment)
AI-Driven Drug Discovery (BioAI Pharma) and Its Impact on Healthcare Equity (2025 Assessment) AI-driven drug discovery is reshaping pharmaceutical development, offering dual implications for healthcare equity: it can accelerate equitable global health resource allocation but may also exacerbate disp … AI-Driven Drug Discovery (BioAI Pharma) and Its Impact on Healthcare Equity (2025 Assessment)Read more
AI-Driven Drug Discovery (BioAI Pharma): Development of Life Science Large Models
AI-Driven Drug Discovery (BioAI Pharma): Development of Life Science Large Models (Comprehensive Analysis Based on 2025 Technological Advances and Industry Practices) 1. Core Architecture and Data Integration in Life Science Models BioAI Pharma relies on multimodal life science models that integrate … AI-Driven Drug Discovery (BioAI Pharma): Development of Life Science Large ModelsRead more
Advances in AI-Powered Gene Editing (AIGenEdit): Optimizing Target Selection, Off-Target Prediction, and Repair Template Design
Advances in AI-Powered Gene Editing (AIGenEdit): Optimizing Target Selection, Off-Target Prediction, and Repair Template Design (As of May 2025) I. Intelligent Breakthroughs in Target Selection AIGenEdit redefines gene-editing efficiency and precision through multimodal data fusion and deep learning … Advances in AI-Powered Gene Editing (AIGenEdit): Optimizing Target Selection, Off-Target Prediction, and Repair Template DesignRead more
Advances in mRNA Velocity for Neurodegenerative and Psychiatric Disorders
Advances in mRNA Velocity for Neurodegenerative and Psychiatric Disorders (As of May 2025) I. Molecular Trajectory Mapping in Neurodegenerative Diseases 1. Early Prediction of Alzheimer’s Disease (AD) Harvard University integrated mRNA velocity with spatial transcriptomics to map gene expression dyn … Advances in mRNA Velocity for Neurodegenerative and Psychiatric DisordersRead more
BioAI Cell: AI-Driven Simulation of Cellular Behavior and Drug Discovery Revolution
BioAI Cell: AI-Driven Simulation of Cellular Behavior and Drug Discovery Revolution (As of May 2025) I. Virtual Cells: Digital Twins in Life Sciences 1. Definition and Core Framework BioAI Cell is an interdisciplinary field that uses AI to simulate, analyze, and manipulate cellular behavior. Key obj … BioAI Cell: AI-Driven Simulation of Cellular Behavior and Drug Discovery RevolutionRead more